Taipei, Taiwan and San Diego, Feb. 7, 2017 - Senhwa Biosciences, Inc. announced the promotion of John Soong M.D., FCAP as Chief Medical Officer today. John Soong has assumed the role on 1st February, 2017 and is based at Senhwa’s US office in San Diego. Dr. John Soong will lead the design of clinical trials and responsible for assessment of other new drug investment and development strategy planning.